Core Insights - Aclarion, Inc. is participating in the Selby Spine Conference to showcase its NOCISCAN platform, which utilizes biomarkers and AI algorithms to assist in identifying chronic low back pain locations [1][2] - Dr. Sigurd Berven will present on how NOCISCAN can help physicians detect biomarkers that are not visible through traditional imaging methods, enabling personalized treatment plans for patients [2][4] Company Overview - Aclarion is a healthcare technology company focused on chronic low back pain, leveraging Magnetic Resonance Spectroscopy (MRS) and proprietary algorithms to optimize clinical treatments [6] - NOCISCAN is the first evidence-supported SaaS platform designed to noninvasively differentiate between painful and nonpainful discs in the lumbar spine, providing critical insights for treatment strategies [4][6] Presentation Details - The presentation titled "MR Spectroscopy, Augmented Intelligence, and Low Back Pain – A New Gold Standard" will highlight the innovative capabilities of NOCISCAN [2][3] - NOCISCAN combines MR Spectroscopy with augmented intelligence to set a new standard for noninvasive diagnostics in spine surgery and chronic pain management [3] Market Context - Chronic low back pain affects approximately 266 million people globally, indicating a significant healthcare challenge that Aclarion aims to address with its technology [4]
Aclarion to Showcase Groundbreaking NOCISCAN Technology at the Selby Spine Conference